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Objectives. We hypothesized that neurohormonal activity con-
tributes to the initiation of sustained ventricular tachycardia (VT)
as reflected in indices of heart rate variability (HRV).
Background. Autonomic nervous system activity participates in
experimental arrhythmias but clinical studies have been inconsis-
tent.
Methods. Holter electrocardiograms from 53 patients with VT
were analyzed. Heart rate variability indices were determined over
5 and 15 min and 24 h and examined for changes before the onset
of VT. Heart rate variability indices in the frequency domain
included ultra low frequency power (FP) (ULFP): 0–0.0033 Hz;
very low FP (VLFP): 0.0033–0.04 Hz; low FP (LFP): 0.04–0.15 Hz;
high FP (HFP): 0.15–0.4 Hz; total power (TP); normalized LFP
(LFPn); normalized HFP (HFPn), and the ratio: LFP/HFP.
Results. Heart rate variability indices were severely diminished:
TP: 12,009 6 11,076 ms2; ULFP: 10,087 6 9,565 ms2; VLFP:
1,416 6 1,571 ms2; LFP: 544 6 620 ms2; HFP: 161 6 176 ms2, and
LFP/HFP: 3.68 6 2.83. Heart rate increased before VT (80.4 6
17.3 to 85.3 6 17.4 bpm, p < 0.001). Several HRV variables
declined 30 min before VT compared to 24-h values (VLFP:
25.89 6 17.81%, p 5 0.031; LFP: 25.23 6 14.3%, p 5 0.003; HFP:
24.35 6 13.7%, p 5 0.04). LFPn and the LFP/HFP ratio decreased
significantly before the onset of VT (217.7 6 46.9%, p 5 0.035 and
28.24 6 38.8%, p 5 0.037, respectively), whereas HFPn increased
slightly (4.29 6 29.9%, p 5 0.097).
Conclusions. Heart rate rose, whereas LFP, LFPn and LFP/
HFP fell before the onset of VT. This pattern of changes could be
explained by a rise in sympathetic activity and saturation of the
HRV signal resulting in dissociation of the average and rhythmi-
cal effects of sympathetic activity. These findings suggest that
alterations in autonomic activity contributed to arrhythmogenesis
in this group of patients.
(J Am Coll Cardiol 1998;32:1891–9)
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Participation of the autonomic nervous system in the genesis of
ventricular tachyarrhythmias and sudden cardiac death is well
documented (1). In animal models increased sympathetic
activity reduces the ventricular fibrillation threshold (2) and
provokes ventricular arrhythmias (3,4), particularly in the
presence of myocardial ischemia (5,6). A protective effect is
exerted by increased vagal activity (7,8), and is most pro-
nounced in the presence of elevated sympathetic tone (9).
There is also convincing evidence for a relation between
autonomic nervous system function and clinical events; ele-
vated norepinephrine levels (10) and increased sympathetic
nerve activity (11) are associated with a poor prognosis,
whereas treatment with beta-adrenergic receptor blockers
reduces mortality after myocardial infarction (12).
Despite progress, however, major gaps in our understand-
ing of the effects of neurohormonal activity on the generation
of clinical ventricular arrhythmias persist. Several temporal
modes of influence can be proposed, each with distinct clinical
implications. One possibility is that short-term changes, for
example, a rise in sympathetic activity or a decline in parasym-
pathetic tone, trigger ventricular tachyarrhythmias in the set-
ting of the appropriate anatomic or functional alterations in
the myocardium. Another possibility is that short-term changes
have no effect, but chronic alterations cause remodeling, that
is, slowly progressive proarrhythmic alterations in myocyte
structure and function (13,14). Still another possibility is that
elevated sympathetic activity and reduced vagal tone create the
necessary conditioning effects on myocardium for arrhythmias
to occur independent of long- or short-term effects (15).
Analysis of spontaneous ventricular arrhythmias could pro-
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vide information about triggers of arrhythmias unobtainable
from experimental models or electrical induction of arrhyth-
mias. We (16,17) and others (18–23) have reported that
isolated and repetitive ventricular ectopic beats rarely resem-
ble sustained ventricular tachycardia induced by programmed
electrical stimulation, and that many episodes of spontaneous
sustained ventricular tachycardia (VT) appear to arise de novo
late in the cardiac cycle in the absence of an identifiable
trigger. Although a number of mechanisms including con-
cealed extrasystoles, sinus beat reentry or occult ischemia
could explain these findings, it is also possible that neurohor-
monal activity is partly responsible for precipitating VT in the
absence of overt electrocardiographic changes. It should be
stressed that the electrocardiographic records of such events
rarely demonstrate ST segment shifts or T-wave changes that
might indicate myocardial ischemia (17–23).
Advances in heart rate variability (HRV) analysis have
provided powerful methods for assessing autonomic nervous
system activity in a wide variety of clinical settings (24–26),
although the interpretation of specific indices remains contro-
versial (27). Studies in experimental animals have demon-
strated a short-term relation between autonomic nervous
system activity and arrhythmogenesis using HRV analysis (28).
Studies of patients after myocardial infarction have validated
the use of indices of HRV for predicting long-term outcome
(29–31). However, studies of short-term (hours to minutes)
changes in HRV indices of autonomic activity before the onset
of spontaneous VT in small groups of patients have been
inconsistent (32–34).
The purpose of this study was to examine the influence of
autonomic nervous system activity on the initiation of sus-
tained ventricular tachyarrhythmias by examining the heart
rate and heart rate variability preceding VT. Several previous
studies were based on recordings collected during the course of
routine clinical practice. In contrast, our study included a
relatively large number of patients whose data were collected
in a uniform, prospective manner during the course of a
clinical trial conducted at 14 clinical centers (35–37). This
could lessen the chance that the circumstances of the record-
ings or types of patients included are biased by local practice
patterns, and it could enhance the homogeneity and reliability
of the findings.
Methods
Patients. Patients for this study were identified by the
presence of spontaneous, sustained ($30 s, rate .100 bpm)
VT on a 24-h Holter recording. The Holter tapes were
obtained from the ESVEM trial, which has been described in
detail (35–37). Patients considered for this trial had a history of
cardiac arrest, documented ventricular fibrillation, sustained
ventricular tachycardia, or syncope. Patients with recent myo-
cardial infarction, the long QT syndrome, hypertrophic cardio-
myopathy or arrhythmias due to transient or reversible disor-
ders were excluded. Enrolled patients had at least 10
premature ventricular complexes per hour and inducible sus-
tained ventricular tachyarrhythmias (35).
Analysis of recordings. The Holter recordings were ob-
tained at least five half-lives after the discontinuation of
antiarrhythmic drugs. Baseline Holter monitor recordings
(1,646 tapes) were obtained in 868 of the 2,103 patients
screened for the trial (36). The tapes were analyzed and
verified as described previously (35). Tapes from 59 patients
demonstrated VT; six with atrial fibrillation were excluded.
Episodes of VT from a single patient may have common
features, and patients with multiple episodes of VT could differ
from patients with a single episode of VT. Therefore, inclusion
of multiple episodes of VT from individual patients would
favor characteristics of patients with more episodes. To avoid
this potential bias, the analysis was restricted to one VT
episode (the longest) per patient.
Electrocardiographic data were digitized at 400 Hz. QRS
complexes were detected and classified on a commercial
system (Burdick, Inc., Milton, WI) using custom software and
verified by a cardiologist. Intervals between normal QRS
complexes were extracted, and a regularly spaced time series
was sampled at a frequency of 2 Hz using a “boxcar” low-pass
filter (38). Gaps in the time series resulting from noise or
ectopic beats were filled in with linear splines, which can cause
a small reduction in high frequency power but do not affect
other components of the power spectrum (39). In some
previous studies, tapes with frequent ectopy were excluded.
However, this could result in a selection bias or loss of
important data. For instance, restriction of data sets to .85%
normal beats would have excluded 40% of the data files. To
assess the impact of including segments with ectopic activity,
Abbreviations and Acronyms
ANOVA 5 analysis of variance
ESVEM 5 Electrophysiologic Study Versus
Electrocardiographic Monitoring
HFP 5 high frequency power
HFPn 5 normalized high frequency power
HR 5 heart rate
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LFPn 5 normalized low frequency power
pNN50 5 percentage of differences between adjacent normal
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we repeated the analyses using intervals with .50%, .75% or
.85% of normal beats.
RR intervals were analyzed in time and frequency domains
over 5- and 15-min intervals and over the entire 24-h period.
Time domain analysis. Mean and standard deviation of
normal RR intervals, the square root of the mean of the
squared differences between adjacent normal RR intervals and
percentage of differences between adjacent normal RR inter-
vals .50 ms were estimated in each 5- and 15-min interval
(40).
Frequency domain analysis. After subtracting the mean
from the time series, power spectral analysis of HRV was
performed using fast Fourier transform and a Hanning win-
dow. Zero padding was applied to increase the outcome
frequency resolution, and the resulting power spectrum was
corrected for the filtering and windowing (38,40). Power
was integrated over each frequency range: high (HFP),
0.15–0.4 Hz; low (LFP), 0.04–0.15 Hz; total (TP), 0.01–0.4 Hz,
and 0.0033–0.4 Hz for 5- and 15-min intervals, respectively;
very low (VLFP), 0.0033–0.04 Hz in 15-min intervals. The ultra
low frequency component (ULFP), 0–0.0033 Hz, was deter-
mined over 24 h. The ratio of low and high frequency power
was calculated. Normalized values were obtained by calculat-
ing the fraction of LFP and HFP variability with respect to the
sum of LFP 1 HFP.
Statistical analysis. Shapiro–Wilks’ W test of normality
was used to assess distribution of the data. Because of substan-
tial deviation from normal distribution, nonparametric Fried-
man analysis of variance (ANOVA) was applied to test the
significance of changes in each variable over time. The signif-
icance of differences between 24-h averaged measures and
intervals prior to VT was assessed with the Wilcoxon matched
pairs test. Different groups of patients were compared using
Kruskal–Wallis ANOVA. Statistical significance did not
change when skewed variables were reanalyzed using logarith-
mically transformed data to normalize the distribution.
ANOVA for repeated measurements was applied to test the
significance of temporal changes in the transformed variables
preceding VT. To compare the logarithmically transformed
variables, t tests, for dependent samples were used. Results are
expressed as mean 6 standard deviation (SD) of the logarith-
mically transformed data unless otherwise indicated. Differ-
ences at p , 0.05 were considered significant.
Results
Clinical characteristics. The mean age of the 53 patients in
this study was 63.9 6 10.3 years, and 13% were women. The
etiology of heart disease was ischemic in 83% of the patients,
and the mean ejection fraction was 33.6 6 16.8% (Table 1).
The mean (6SD) duration of the index arrhythmia was 13.4 6
24.5 min (median was 2.77 min, range 30 s to 117 min), and
mean cycle length was 369 6 83 ms (median 352 ms, range 206
to 569 ms). The frequency of VT was higher during day than
during night, peaking in the morning and late afternoon (Fig.
1).
Twenty-four hour heart rate variability indices. Time do-
main indices of HRV were severely reduced: SDNN: 83.3 6
40.2 ms (ln: 4.31 6 0.49); SDANN index: 73.4 6 36.9 ms (ln:
4.18 6 0.50); SDNN index: 34.3 6 19.4 ms (ln: 3.36 6 0.62);
r-MSSD: 24.4 6 15.1 ms (ln: 3.04 6 0.56), pNN50: 4.48 6
5.09% (ln: 0.97 6 1.05) (28). Frequency domain variables were
similarly depressed (40): TP: 12,209 6 11,076 ms2 (ln: 8.88 6
1.22); ULFP: 10,087 6 9,565 ms2 (ln: 8.66 6 1.25); VLFP:
Table 1. Clinical Characteristics of Patients With and Without Recorded Spontaneous
Ventricular Tachycardia
Study All SpVT No SpVT p* p†
Number in each group‡ n 5 53 n 5 59 n 5 440
Age (years) 64.1 6 10.3 64.5 6 10.3 64.5 6 9.7 0.61 0.99
Female 7 (13) 9 (15) 55 (13) 0.42 0.56
Presenting event
VF or sudden death 6 (11) 7 (11) 98 (22) 0.14 0.051
VT or syncope 47 (89) 52 (88) 342 (78)
Ischemic heart disease 44 (83) 47 (80) 373 (85) 0.14 0.37
Years since last MI mean 5.7 6 6.7 5.9 6 6.8 8.3 6 8.3 0.13 0.049
(median) (2.5) (2.5) (6.4)
SAS class 3 or 4 14 (26) 16 (27) 134 (30) 0.82 0.59
Ejection fraction (%) 36 6 15 35 6 2 32 6 12 0.10 0.11
PVC/h on Holter 419 6 541 371 6 505 304 6 385 0.12 0.2
(median) (179) (151) (170)
Digitalis 10 (25) 14 (30) 165 (38) 0.09 0.34
Verapamil or diltiazem 6 (15) 6 (13) 63 (14) 0.39 0.81
Beta-blocker 4 (10) 5 (11) 59 (13) 0.79 0.62
*This group versus patients without spontaneous VT. †Patients with spontaneous VT versus patients without
spontaneous VT. ‡Percentages are in parentheses except where indicated, and reflect missing data for some variables.
Beta-blocker 5 beta-adrenergic receptor blocking drug; MI 5 myocardial infarction; PVC 5 premature ventricular
complexes; SAS 5 Symptomatic Activity Scale; SpVT 5 spontaneous sustained monomorphic VT; VF 5 ventricular
fibrillation; VT 5 ventricular tachycardia.
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1,416 6 1,571 ms2 (ln: 6.48 6 1.52); LFP: 544 6 620 ms2 (ln:
5.41 6 1.55); HFP: 161 6 176 ms2 (ln: 4.49 6 1.22), and
LFP/HFP: 3.68 6 2.83 (ln: 0.99 6 0.96).
Heart rate before ventricular tachycardia. Heart rate was
significantly higher 30 min before the onset of arrhythmia
(85.3 6 17.4 bpm) compared to 2 h before VT (80.4 6
17.3 bpm, p , 0.001) or compared to the 24-h mean (80.8 6
19.1 bpm, p , 0.001) (Fig. 2).
Heart rate variability before ventricular tachycardia. Time
domain indices of HRV (standard deviation, r-MSSD and
pNN50) did not change significantly prior to the onset of VT
either by comparison of the mean 24-h value to the 30- and
60-min period before VT, or by comparison of the 30- and
60-min periods between 4 and 1 h before VT.
Frequency domain measures were lower in the 30-min
period immediately preceding VT (ln TP 5 6.85 6 1.38, ln
VLFP 5 6.22 6 1.82, ln LFP 5 5.17 6 1.47, ln HFP 5 4.41 6
1.15, LFP/HFP 5 3.30 6 2.42) compared to the 24-h average
values (ln TP 5 7.05 6 1.10, p 5 0.061; ln VLFP 5 6.53 6 1.32,
p 5 0.031; ln LFP 5 5.47 6 1.37, p 5 0.003; ln HFP 5 4.57 6
0.97, p 5 0.043; LFP/HFP 5 3.85 6 3.08, p 5 0.042). The most
prominent drop was in the LFP (Fig. 3c). Normalized LFP
(LFPn) was also lower at 30 min before VT (ln: 20.52 6 0.55)
compared to the 24-h value (ln: 20.46 6 0.49, p 5 0.037).
Normalized HFP (HFPn) was slightly increased at 30 min
before VT (ln: 21.25 6 0.61) compared to the 24-hour average
(21.32 6 0.59, p 5 0.097). The patterns of change in frequency
domain variables were assessed by analysis of variance from 2 h
to 30 min before onset of VT. Low frequency power and HFP
declined significantly during this period (p 5 0.024, p 5 0.022,
respectively). A marginally significant (p 5 0.098) decline of
the ratio LFP/HFP occurred, indicating that the decrease of
LFP was larger than the fall in HFP.
The relationships between the changes in heart rate (HR)
and the ratio LFP/HFP varied within as well as among
individual patients. In Figure 4 the two variables increased
concordantly several hours before VT, but 1 h before VT the
changes were discordant, that is, HR increased, whereas
LFP/HFP declined.
Effects of ectopic beat frequency. To assess the influence of
ectopic activity on the spectral power of HRV we compared
the results of analyses that included intervals with .50%,
.75% or .85% of normal beats (Fig. 5). Although the
absolute values of VLFP, LFP, HFP, TP and LFP/HFP, and
the number of time intervals that were acceptable for analysis
decreased as the threshold increased from 50% to 85%, the
changes in all the spectral characteristics were similar. Thus,
changing the threshold for ectopic beat frequency data seg-
ment selection did not alter the finding of significant reduction
in VLFP, LFP and LFP/HFP preceding VT, and the lack of
significant change in HFP variability.
Relationship between HRV indices and clinical character-
istics of patients. Mean HR over 24 h was higher in women
than in men (84.8 6 12.9 vs. 74.6 6 14.2, p 5 0.05). Among all
the HRV indices, a correlation with borderline statistical
significance with ejection fraction (33 6 17%) was found only
for the low frequency power (r 5 0.40, p 5 0.07). There were
no other significant associations between HRV indices and
age, gender, ejection fraction or the number of ectopic beats.
Discussion
Main results. The patients included in this investigation
were referred for evaluation and management of known or
suspected sustained ventricular tachyarrhythmias. We analyzed
all Holter tapes acquired for the baseline evaluation of the
ESVEM trial, and included all patients in sinus rhythm with a
recorded episode of VT. The patients in this study had
significant structural heart disease due, in most cases, to
previous myocardial infarction. The patients in this study were
not found to differ from the other patients enrolled in the
ESVEM trial with respect to numerous prospectively collected
clinical variables (17,37). The most important finding was
evidence of significant changes in autonomic activity preceding
the onset of VT.
Previous studies. Controversy exists regarding heart rate
increases and the implications for changes in autonomic activ-
ity before the onset of spontaneous ventricular tachyarrhyth-
mias. Increases in heart rate preceding the onset of sustained
ventricular tachyarrhythmias have been observed in a number
of studies (19,33,41–43), but not in others (21,44,45). Leclercq
and colleagues noted that heart rate declined before the onset
Figure 2. Heart rate (HR). Mean of 24-h and 30-min averages before
the onset of ventricular tachycardia (VT). ***The differences are
significant at p , 0.001 compared to the 24-h average.
Figure 1. Circadian distribution of ventricular tachyarrhythmias (VT)
in the studied group.
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of ventricular fibrillation that was initiated by drug-induced
torsade de pointes ventricular tachycardia. However, they
found that heart rate increased before other types of onset of
ventricular fibrillation, and they attributed this effect to a rise
in sympathetic activity (19). The magnitude of the rise they
observed (83 to 92 bpm) was very similar to the change in heart
rate found in the present investigation. This not only supports
the consistency of our findings, but suggests that our observa-
tions may apply to other forms of ventricular tachyarrhythmias.
Although heart rate increases before ventricular tachyar-
rhythmias have been interpreted by several investigators as
indicating an increase in sympathetic tone (19,34,41,43), heart
rate is a relatively nonspecific sign in isolation. Several inves-
tigators have used time domain HRV analysis to assess
changes before sustained ventricular arrhythmias. Singer and
Ori reported in an early study that a time domain measure of
HRV fell during the 5-min period immediately preceding
ventricular fibrillation (46). Recently, Pozzati et al. (47) re-
ported reductions in SDNN before sustained ventricular ar-
rhythmias, but these were preceded by ST segment shifts due
to acute myocardial ischemia and probably do not apply to the
current observations. In concert with our observations, other
earlier studies have failed to find changes in time domain
indices of HRV before VT (48,49).
Frequency domain HRV variables provide more specific
information about autonomic activity (24–26). Although the
published experience is limited in this area, our results are
consistent with the findings of Huikuri et al. (33), who reported
significant reductions in frequency domain indices before 12
episodes of sustained monomorphic VT in eight patients. They
found that all HRV frequency components were lower before
VT compared to nonsustained ventricular tachycardia, and all
frequency components demonstrated reduced power com-
pared to the 24-h average in six patients with both sustained
and nonsustained ventricular tachycardia. Consistent with our
findings and other subsequent investigations, they found that
HFPn did not change before VT. In two subsequent reports,
however, these investigators failed to find significant changes
in the frequency domain measures of HRV before sustained
ventricular arrhythmias (42,49). These inconsistencies may be
related to low statistical power due to the small number of
subjects (8, 8 and 15 patients with VT, respectively, in three
studies [33,42,49]). In addition, studies based on episodes of
VT rather than on individual patients could result in a greater
influence of those patients with more episodes of VT. Clinical
differences in the patients studied is another likely source of
differences. Nevertheless, in the study of Valkama et al. (42),
LFP was the strongest factor associated with the occurrence of
a sustained ventricular arrhythmia on the Holter. Although
statistical significance was not achieved, a clear trend for
Figure 3. Frequency components of the heart rate variability signal,
24-h average and at 30-min intervals before the onset of sustained
ventricular tachycardia. (a) Total power (TFP). (b) Ratio of low to
high frequency power (LFP/HFP). (c) Low frequency power. (d) High
frequency power. (e) Normalized low frequency power. (f) Normalized
high frequency power. *p , 0.05 for comparison 30-min versus 24-h
average. **p , 0.01 compared to the 24-h average. nu 5 normalized
units. Significance of changes during 2-h period before ventricular
tachycardia was assessed by analysis of variance and is discussed in the
text.
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reduction in LFP and VLFP was present before the onset of
VT in the two studies (42,49). Moreover, despite the lack of
significant changes in HRV preceding sustained spontaneous
ventricular arrhythmias, the investigators concluded that
changes in autonomic balance are likely to play an important
role in initiation of the observed sustained arrhythmias (42,49).
Relation of heart rate and heart rate variability to changes
in autonomic nervous system activity before spontaneous
ventricular arrhythmias. Withdrawal of parasympathetic ner-
vous system activity has been proposed as an arrhythmogenic
mechanism (1,28) and could account for increases in heart rate
before ventricular arrhythmias. Time domain measures of
heart rate variability may reflect vagal activity (26,28), but none
of these variables was found to change significantly before VT.
High frequency power, a proposed marker of vagal tone, fell
significantly before VT, but the LFP/HFP ratio also declined,
indicating a relatively greater drop in LFP. Moreover, HFPn, a
more specific index of parasympathetic activity (25), increased
slightly. Furthermore, a significant reduction of vagal tone
would be less likely in patients with chronic severe left
ventricular dysfunction who are believed to have reduced
parasympathetic activity and increased sympathetic tone.
These findings do not support withdrawal of vagal activity as
the mechanism for increased heart rate or for VT initiation in
this group of patients.
The rise in heart rate that preceded VT was most likely due
to increased sympathetic activity as proposed in several previ-
ous studies (15,19,33). An unexpected but intriguing finding
was the paradoxical fall in the low frequency components that
accompanied the rise in heart rate. In normal subjects, the
LFP/HFP ratio and LFPn usually rise and fall in concert with
heart rate in response to maneuvers that increase and decrease
sympathetic activity, respectively (24,25). Instead, we observed
a modest decline in LFPn and LFP/HFP before VT, whereas
heart rate increased.
The HRV indices can provide only inferential evidence of
the changes in autonomic tone and cannot definitively prove
that the mechanism is increasing sympathetic tone and not
declining parasympathetic tone or a combination of the two
effects. Both increasing sympathetic and decreasing parasym-
pathetic tone would result in a relative increase in sympathetic
activity. However, we consider the increasing sympathetic tone
to be the most likely mechanism of the observed HRV
changes. The drop in LFP was predominant, causing a de-
crease in the LFP/HFP ratio and an increase in the normalized
HFP. The relationships between the sympathetic and parasym-
pathetic effects often do not correspond to the changes in
normalized low and high frequency powers (27). Thus an
increase in the normalized HFP prior to VT might not indicate
the elevated parasympathetic tone, and the diminished para-
sympathetic activity, as manifested by decreased HFP, cannot
Figure 4. Changes in heart rate (top panel) and the low to high
frequency power ratio (LFP/HFP) (bottom panel) during 4 h before
ventricular tachycardia (VT) in an individual patient. See text for
discussion.
Figure 5. Spectral changes in the
total (TFP) (a), low frequency (LFP)
(b) and high frequency (HFP) (c)
power and low/high frequency ratio
(d) preceding the arrhythmia with
respect to ectopic beat frequency.
Power spectral analysis was repeated
after removal of data segments not
meeting the frequency threshold cri-
teria: .50%, .75% and .85% nor-
mal beats. *p , 0.05 compared to the
24-h average. **p , 0.01 compared
to the 24-h average.
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be ruled out as a contributing factor in the observed HRV
changes.
These paradoxical changes are most likely a consequence of
preexisting abnormalities in autonomic function and disturbed
response characteristics in patients with chronic severe myo-
cardial dysfunction and ventricular tachyarrhythmias. Evi-
dence for neurohormonal dysfunction has been demonstrated
by measurements of myocardial norepinephrine spillover ki-
netics, an established measure of sympathetic traffic to the
heart (50). Myocardial norepinephrine spillover is elevated at
rest in patients with left ventricular dysfunction (50,51). Ma-
neuvers that stimulate sympathetic activity, such as exercise
and nitroprusside-induced hypotension, cause a rise in norepi-
nephrine spillover, but the response is attenuated in patients
with cardiac dysfunction (50,51). Additional evidence for pre-
existing abnormalities of autonomic function is the chronic
depression of LFP despite high resting sympathetic activity in
patients with left ventricular dysfunction. The degree of dim-
inution of LFP and other components of HRV have been
found to be predictors of mortality after myocardial infarction
(30). van de Borne et al. (11) recently demonstrated marked
reductions of LFP despite prominent increases of sympathetic
nerve activity in patients with severe heart failure. Indeed,
patients whose low frequency variability had become undetect-
able had higher levels of sympathetic nerve activity, lower
ejection fractions and greater mortality. Guzzetti et al. (52)
showed that the amplitude of the LFP was related to the
severity of left ventricular dysfunction. LFP was above normal
in patients with increased sympathetic activity associated with
mild to moderate left ventricular dysfunction. Patients with
more severe cardiac dysfunction, who are known to have
higher levels of sympathetic activity, had the lowest values of
LFP, consistent with the findings of van de Borne et al. (11).
The change in the low frequency component in response to
maneuvers that increase sympathetic activity was noteworthy.
In contrast to normal subjects, in whom LFP increases with
head-up tilt, patients with moderate or severe chronic heart
failure demonstrated a marked decrement in LFP (52). A
paradoxical decline in LFP in response to exercise was also
demonstrated in an animal model of congestive heart failure
(53).
The rise in heart rate and fall in LFP, LFPn and LFP/HFP
indicate a paradoxical dissociation between the rise in the
average effects of increased sympathetic activity as reflected by
increased heart rate, and a fall in the rhythmical effects of
increased sympathetic activity, as indicated by the drop in low
frequency HRV. These two components become dissociated
when their changes approach the limits of physiologic dynamic
range (54). Therefore, the dissociation between average and
phasic facets of sympathetic activity strongly suggests that
sympathetic activity is rising from an already abnormally high
level immediately before VT as expected based on measure-
ments of myocardial norepinephrine spillover (50,51). The
extent of the rise of sympathetic activity, however, is difficult to
estimate, as its physiologic manifestations approach the limits
of their dynamic ranges and the signals they generate become
saturated. The HRV signal reflects sinus node function. It is
important to recognize that the dynamic range of sinus node
function is not necessarily the same as other effects of sympa-
thetic activity. Hence the electrophysiologic properties rele-
vant to VT initiation may be undergoing changes in response
to rising sympathetic tone that are out of proportion to the
changes measured in the HRV signal.
The mechanism of this phenomenon is unknown. It could
result from properties intrinsic to the sinus node or extrinsic
factors. Proposals include altered sinus node responsiveness to
high levels of cardiac sympathetic activation (54), beta-
adrenergic receptor down-regulation (11), and compromised
central autonomic regulatory functions due to elevated levels
of catecholamines, angiotensin or vasopressin (11). Another
possible mechanism of this phenomenon is a shift of LFP to
the lower frequencies, which was previously found in the same
group of patients (55,56).
There are diurnal variations in the occurrence of ventricular
tachycardia and HRV (57–59). In this group, the frequency of
VT was higher during day than during night, peaking in the
morning and late afternoon. These peaks coincided with the
peaks of the 24-h heart rate distribution in this group and the
reported peaks of plasma catecholamine concentration
(60,61). Thus circadian changes in the autonomic activity could
have an impact on the changes in heart rate and heart rate
variability preceding VT in some patients. However, the drop
in LFP before the onset of arrhythmia did not correspond to
the morning increase in LFP in patients with congestive heart
failure (58) and survivors of cardiac arrest (59). The circadian
changes in HRV are severely diminished in this population and
do not demonstrate any pronounced variations in LFP, which
might resemble those before the onset of VT (62). This
suggests that circadian variations taken in isolation cannot be
a sole factor causing the changes in heart rate and HRV before
VT.
Although LFP reflects autonomic modulation of the cardiac
cycle, other physiologic processes, including arterial pressure
and muscular sympathetic nerve activity, demonstrate modu-
lation at the same frequency and tight correlation to HRV in
response to interventions that change autonomic tone (25,63).
Thus LFP may reflect systemic effects of autonomic nervous
system function. Our findings, and the work of others, demon-
strate the dual nature of autonomic activity, that is, its average
and rhythmical components (11,64). The average component is
manifested not only as heart rate, but also as the burst rate of
muscular sympathetic nerve activity (11,63). The phasic com-
ponent is manifested as the LFP in the HRV signal as well as
other physiologic processes, including variabilities of arterial
pressure, muscular sympathetic nerve activity, temperature
and vasomotor activity (11,57,63,65,66).
Limitations. Our study is subject to several important
limitations. Changes in heart rate prior to the onset of VT
might violate the assumption of stationarity of the signal, which
is required in conventional spectral analysis. However, analyses
performed at both 5- and 15-min segments suggested that
transients resulting from changes in heart rate did not contrib-
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ute significantly to the findings. Application of the Hanning
window prior to the spectral analysis also attenuates the effects
of nonstationarities and discontinuities. A more important
limitation is that our observations are based on post hoc
analyses of data recorded on 24-h electrocardiograms, and
there was no opportunity to measure autonomic nervous
system activity by more direct techniques that could corrobo-
rate our findings. The results of HRV analysis could be
affected by several factors, including the organic heart disease,
the gain of interaction between the neural activity and the
sinus node, humoral milieu, receptor transduction properties
and different respiration patterns. The impact of these factors
could not be examined in this study.
Moreover, in a strict sense, our findings apply only to the
population represented by the subjects selected. In most of the
patients we studied the presenting arrhythmia did not result in
ventricular fibrillation, and a minority required an acute inter-
vention to terminate the arrhythmia (17). On the other hand,
the subset of the clinical trial patients selected for this analysis
did not differ significantly from the other patients in the
ESVEM trial with respect to clinical or outcome variables (17).
Many characteristics of the patients we studied are similar to
those in previous studies of ambulatory recordings obtained in
patients who died suddenly or had cardiac arrests and which
provided evidence of the contribution of increasing sympa-
thetic drive to arrhythmogenesis (19). Further research will be
required to determine if our findings apply to other groups of
patients at risk for ventricular tachyarrhythmias.
The alterations in HRV indices that preceded the onset of
VT were observed at other times during the 24-h recordings.
This supports the concept that multiple factors contribute to
arrhythmogenesis and justifies a multicomponent approach to
the prediction of VT (67).
Conclusions. We conclude that alterations in autonomic
activity precede the onset of sustained ventricular tachycardia
in some patients. The changes in HRV cannot be linked to a
specific change in autonomic activity with certainty, and a
causal relation to the onset of VT cannot be proven in the
context of this study. Nevertheless, instead of the parallel rise
in average and rhythmical manifestations of increased sympa-
thetic activity seen at low or moderate levels of sympathetic
stimulation in normal subjects, we found spontaneous dissoci-
ation of these two facets of autonomic activity immediately
before the onset of ventricular tachyarrhythmias. This mis-
match of phasic and average components of altered neurohor-
monal activity appears to be a sign of a critical aspect of the
arrhythmogenic process, and it may be a crucial contributor. If
so, it may be possible to use this phenomenon to predict
impending arrhythmic events, and it could be an important
target for antiarrhythmic protection.
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